Cite
HARVARD Citation
Frenck, R. et al. (2016). Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older. Vaccine. 34 (30), pp. 3454-3462. [Online].